Evidence map›Paper›PMID 36477468›Full record

ArticleScientific reports2022

High-throughput primer design by scoring in piecewise logistic model for multiple polymerase chain reaction variants.

Huaping Zeng, Kexin Chen, Chouxian Ma, Biyin Zhu, Jun Chuan, Shuan Zhang, Lin Tang, Ting Yang, Zhaohui Sun, Xingkun Yang and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Huaping Zeng *GeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Kexin Chen *GeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Chouxian Ma *GeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Biyin Zhu *GeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Jun ChuanGeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Shuan ZhangGeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Lin TangGeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Ting YangGeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Zhaohui SunGeneTalks Biotech Co., Ltd., Changsha, 410000, Hunan, China.
Xingkun YangAffliated Foshan Maternity & Child Healthcare Hospital, Southern Medical University, Foshan, 528000, Guangdong, China.
Yu WangSchool of Life Sciences and Technology, Tongji University, Shanghai, 200092, China. 2180212@tongji.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymerase chain reaction (PCR) variants requiring specific primer types are widely used in various PCR experiments, including generic PCR, inverse PCR, anchored PCR, and ARMS PCR. Few tools can be adapted for multiple PCR variants, and many tools select primers by filtration based on the given parameters, which result in frequent design failures. Here we introduce PrimerScore2, a robust high-throughput primer design tool that can design primers in one click for multiple PCR variants. It scores primers using a piecewise logistic model and the highest-scored primers are selected avoiding the issue of design failure and the necessity to loosen parameters to redesign, and it creatively evaluates specificity by predicting the efficiencies of all target/non-target products. To assess the prediction accuracy of the scores and efficiencies, two next generation sequencing (NGS) libraries were constructed-a 12-plex and a 57-plex-and the results showed that 17 out of 19 (89.5%) low-scoring pairs had a poor depth, 18 out of 19 (94.7%) high-scoring pairs had a high depth, and the depth ratios of the products were linearly correlated with the predicted efficiencies with a slope of 1.025 and a coefficient of determination (R

Indexed as

Logistic ModelsHumansMalePolymerase Chain Reaction

Identifiers

PMID36477468
PMCPMC9729204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.